Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Insulin Pilot in NASH
NCT02653300Phase 2Completed
- Sponsor
- Oramed Pharmaceuticals Inc.
- Start
- Sep 2018
- Primary completion
- Mar 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ORMD-0801 in Nonalcoholic steatohepatitis (NASH), sponsored by Oramed Pharmaceuticals Inc.. Started Sep 2018; status: completed.
02
Drugs
ORMD-0801
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02653300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653300.